evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

633 questions · 668 findings · 122 reviews · Headline outcomes only

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 144 · 21.6%GRADE not reported 27 · 4%Very low 154 · 23.1%Low 194 · 29%Moderate 119 · 17.8%High 30 · 4.5%

Tacrolimus 0.1% vs vehicle

Secondary: investigator‐rated reduction in severity ‐ Not measured · people with moderate to severe nickel sulphate‐induced allergic contact dermatitis based on clinical history (hand eczema) and proven by…

The review found no eligible studies for this question.

1 finding from 1 review

Micronutrient or macronutrient supplementation interventions in children vs no intervention, or placebo to reduce stunting (height‐for‐age, length velocity, and length at 12 months)

Stunting · children under 5 years old

Micronutrient or macronutrient supplementation interventions in… showed no clear difference in height‐for‐age (z‐score) compared with no intervention, or placebo to reduce stunting (height‐for‐age,… (low certainty).

1 finding from 1 review

Micronutrient or macronutrient supplementation interventions in children vs no intervention, or placebo to reduce stunting (height‐for‐age, length velocity, and length at 12 months)

Height‐for‐age (z‐score) Length gain (6 months) · children under 5 years old
1 finding from 1 review

Micronutrient or macronutrient supplementation interventions in children vs no intervention, or placebo to reduce stunting (height‐for‐age, length velocity, and length at 12 months)

Height‐for‐age (%) at 18 months, 21 months Length gain · children under 5 years old
1 finding from 1 review

Micronutrient or macronutrient supplementation interventions in children vs no intervention, or placebo to reduce stunting (height‐for‐age, length velocity, and length at 12 months)

Length velocity (change in cm since start of supplementation) · children under 5 years old
1 finding from 1 review

Micronutrient or macronutrient supplementation interventions in children vs no intervention, or placebo to reduce stunting (height‐for‐age, length velocity, and length at 12 months)

Length velocity (cm/month) · children under 5 years old

It is very uncertain whether micronutrient or macronutrient supplementation interventions in… changes length velocity (cm/month) compared with no intervention, or placebo to reduce stunting (height‐for‐age,… (very low certainty).

1 finding from 1 review

Micronutrient or macronutrient supplementation interventions in children vs no intervention, or placebo to reduce stunting (height‐for‐age, length velocity, and length at 12 months)

Length (cm) · children under 5 years old

Micronutrient or macronutrient supplementation interventions in… showed no clear difference in length (cm) at 12 months compared with no intervention, or placebo to reduce stunting (height‐for‐age,… (low certainty).

1 finding from 1 review

Summary of findings table ‐ LUNA (laparoscopic uterosacral ligament nerve ablation) vs diagnostic laparoscopy/other treatments

Effectiveness of treatment · health problem or population
3 findings from 1 review

Angiotensin receptor blockers (ARBs) vs placebo or no treatment

Micro‐ to macroalbuminuria Median · people with diabetes and kidney disease

Angiotensin receptor blockers may leads to lower micro‐ to macroalbuminuria Median compared with placebo or no treatment (low certainty).

1 finding from 1 review

Angiotensin receptor blockers (ARBs) vs angiotensin‐converting enzyme inhibitors (ACEis)

Micro‐ to macroalbuminuria Median · people with diabetes and kidney disease

Angiotensin receptor blockers showed no clear difference in micro‐ to macroalbuminuria Median compared with angiotensin‐converting‐enzyme inhibitors (low certainty).

1 finding from 1 review

Angiotensin‐converting enzyme inhibitors vs ACEi plus angiotensin receptor blockers

Micro‐ to macroalbuminuria Median · people with diabetes and kidney disease

It is very uncertain whether angiotensin‐converting‐enzyme inhibitors (ACEi) alone changes micro‐ to macroalbuminuria Median compared with ACEi plus angiotensin receptor blockers (very low certainty).

1 finding from 1 review

Angiotensin receptor blockers (ARB) alone vs angiotensin‐converting‐enzyme inhibitors plus ARB

Micro‐ to macroalbuminuria Median · people with diabetes and kidney disease

Angiotensin receptor blockers (ARB) alone showed no clear difference in micro‐ to macroalbuminuria Median compared with angiotensin‐converting‐enzyme inhibitors plus ARB (low certainty).

1 finding from 1 review